UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046443
Receipt number R000052992
Scientific Title Evaluation of the usefulness of a swallowing electrical stimulator in maintaining swallowing function in patients after extubation: a randomized controlled trial
Date of disclosure of the study information 2022/01/04
Last modified on 2022/09/08 15:06:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of the usefulness of a swallowing electrical stimulator in maintaining swallowing function in patients after extubation: a randomized controlled trial

Acronym

Evaluation of the usefulness of a swallowing electrical stimulator in maintaining swallowing function in patients after extubation: a randomized controlled trial

Scientific Title

Evaluation of the usefulness of a swallowing electrical stimulator in maintaining swallowing function in patients after extubation: a randomized controlled trial

Scientific Title:Acronym

Evaluation of the usefulness of a swallowing electrical stimulator in maintaining swallowing function in patients after extubation: a randomized controlled trial

Region

Japan


Condition

Condition

post-extubation dysphagia(PED)

Classification by specialty

Intensive care medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the hypothesis that swallowing rehabilitation with NMES (neuromuscular electrical stimulation) is more effective than regular rehabilitation alone in improving swallowing function in patients with PED.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

FOIS (functional oral intake scale)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

In the NMES group, in addition to the usual swallowing rehabilitation (tongue exercise, TTS: thermal-tactile stimulation [cold pressure stimulation], Mendelsohn maneuver), NEMS will be attached to the mandible and swallowing rehabilitation will be performed. Interventions for both groups will be 30 minutes per session, 5 times per week. In the NMES group, the upper limit of the frequency that is not painful to the patient will be used, and stimulation will be repeated for 5 seconds followed by 15 seconds of rest (3 sessions per minute, 90 sessions in total). In the NMES group, patients will be stimulated for 5 seconds at the upper limit of non-painful frequency, followed by 15 seconds of rest (3 sessions per minute, total 90 sessions per session).

Interventions/Control_2

Only normal rehabilitation is performed, and the same observation and evaluation as in the intervention group is performed.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) The patient is in the intensive care unit of Hitachi General Hospital.
2) Age over 20 years at the time of obtaining consent
3) The patient who has been extubated after tracheal intubation
4) The patient who is able to perform swallowing movements but has swallowing dysfunction (FOIS 1-5)
5) The patient has been fully explained about the research, and written consent of his/her own or his/her representative's free will has been obtained with sufficient understanding

Key exclusion criteria

1) Patients who have not taken orally prior to ICU admission (FOIS 2 or lesser)
2) After implantation of artificial heart or pacemaker
3) Gastric banding (PEG) or percutaneous transesophageal gastric tube (PTEG) installation
4) After tracheostomy
5) After head and neck or esophageal surgery
6) Anatomical problem or infection in the mandible that prevents the application of the electrode
7) Disorders of consciousness due to severe head trauma (GCS 13 or lesser)
8) Cognitive dysfunction with MMSE 21 or lesser
9) Patients who have already been included in this study
10) Informed consent could not be obtained
11) Patients deemed unsuitable as subjects by the principal investigator

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Yuji
Middle name
Last name Takahashi

Organization

Hitachi general hospital

Division name

Emergency and Critical Care Medicine

Zip code

3170077

Address

2-1-1, johnancho, Hitachi, Ibaraki, Japan

TEL

0294231111

Email

yuji.mail@me.com


Public contact

Name of contact person

1st name Yuji
Middle name
Last name Takahashi

Organization

Hitachi general hospital

Division name

Emergency and Critical Care Medicine

Zip code

3170077

Address

2-1-1, Johnancho, Hitachi, Ibaraki, Japan

TEL

0294231111

Homepage URL


Email

yuji.mail@me.com


Sponsor or person

Institute

Hitachi general hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research ethics committee of corporative hospital group

Address

2-1-1, Johnancho, Hitachi, Ibaraki, Japan

Tel

0294231111

Email

yuji.mail@me.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 01 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 12 Month 22 Day

Date of IRB

2021 Year 10 Month 25 Day

Anticipated trial start date

2022 Year 07 Month 01 Day

Last follow-up date

2023 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 12 Month 22 Day

Last modified on

2022 Year 09 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052992